TABLE 3.
Clinical samples | ||||
| ||||
No. | Patient sex/age (years) | Sample type | Orien16S Cta value | References |
1 | Male/43 | Eschar | 31.76 | (5, 7) |
2 | Male/56 | Eschar | 24.65 | (5, 7) |
3 | Male/56 | Buffy coat | 35.62 | (5, 7) |
4 | Male/25 | Eschar | 29.76 | (5, 18) |
5 | Male/69 | Eschar | 25.65 | (5, 7) |
6 | Male/69 | Buffy coat | 29.77 | (5, 7) |
7 | Female/22 | Eschar | 27.38 | (5, 7) |
8 | Male/25 | Eschar | 28.09 | (5, 7) |
9 | Male/39 | Eschar | 28.76 | (5, 7) |
10 | Male/39 | Buffy coat | 26.8 | (5, 7) |
11 | Male/28 | Eschar | 31.58 | (5, 7) |
12 | Male/28 | Buffy coat | 32.85 | (5, 7) |
13 | Female/21 | Eschar | 25.99 | (5, 7) |
14 | Male/20 | Eschar | 29.41 | (17) |
15 | Male/17 | Eschar | 35.54 | (17) |
16 | Male/55 | Eschar | 34.16 | (4, 7) |
17 | Male/73 | Eschar | 30.97 | (7) |
18 | Female/49 | Eschar | 27.12 | (7) |
19 | Female/49 | Buffy coat | 35.12 | (7) |
20 | Female/30 | Eschar | 24.35 | (7) |
21 | Male/54 | Eschar | 25.12 | (7) |
22 | Male/63 | Eschar | 26.28 | (7) |
23 | Female/23 | Eschar | 28.4 | (7) |
24 | Male/53 | Eschar | 23.45 | (7) |
25 | Male/41 | Eschar | 24.55 | (7) |
26 | Female/54 | Eschar | 26.82 | (7) |
27 | Male/44 | Eschar | 29.39 | (18) |
28b | Male/62 | Eschar | 29.23 | (16) |
| ||||
Mite samples | ||||
| ||||
No. | Sample ID | Sample type | Orien16S Ct value | References |
| ||||
1 | A olivacea/site4_1 | Mite pool | 33.48 | (11) |
2 | A olivacea/site4_4 | Mite pool | 30.94 | (11) |
3 | A sanborni/site4_1 | Mite pool | 33.14 | (11) |
4 | A olivacea/site6_1 | Mite pool | 31.64 | (11) |
aCt, cycle threshold. Ct value of 36 was used as the cut-off for Orien16S.
bThe infection for sample No. 28 was from South Korea and the rest were acquired in Chile.